United Kingdom

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

5:32pm GMT
Change (% chg)

$0.15 (+2.65%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Roger Pomerantz

61 2019 Chairman of the Board

Eric Shaff

42 2019 President, Chief Executive Officer, Director

John Aunins

57 2012 Chief Technology Officer, Executive Vice President - Bioprocess and Manufacturing

David Cook

60 2012 Chief Scientific Officer, Executive Vice President - Research & Development

Thomas DesRosier

63 2016 Chief Legal Officer, Executive Vice President and Secretary